Latest in Cardiology from ACC.org

• PRAGUE-25: What Is the Best Intervention Strategy For AFib In Obesity?
  Catheter ablation (CA) was superior to a combination of lifestyle modification (LFM) and antiarrhythmic drugs (AADs) in improving freedom from atrial fibrillation (AFib) at one year in patients with obesity, according to results from the PRAGUE-25 trial published in JACC.
• June AMA House of Delegates Key Takeaways
  The American Medical Association (AMA) House of Delegates met in June to discuss and vote on the latest round of proposed resolutions aimed at guiding AMA’s policies on key medical, ethical and public health issues.
• SWISS-APERO: Similar 3-Year Ischemic Risk With Amulet vs. Watchman FLX
  While there was no significant difference in ischemic risk in patients with atrial fibrillation between the Amulet and Watchman FLX devices at three years following left atrial appendage closure (LAAC), according to findings from the SWISS-APERO trial published in JACC...
• ACCEL Lite: Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF
  In this interview, Drs. Matthew Martinez and Barry Borlaug discuss “Hemodynamic Assessment for Diagnosis and Treatment Selection in HFpEF.”
• Editors' Corner | Bridging Innovation and Practice
  Digital health technologies (DHTs) – from remote patient monitoring and virtual care to AI-powered data analysis – hold significant promise for enhancing the prevention, diagnosis and treatment of cardiovascular disease.